Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
NovAccess Global Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
XSNX
Over the counter
8731
https://novaccessglobal.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for NovAccess Global Inc
NovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of Shareholders
- Mar 1st, 2024 2:00 pm
NovAccess Global Announces $10.7 Million Financing
- Jan 2nd, 2024 1:00 pm
NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit
- Dec 1st, 2023 9:51 pm
NovAccess Global Appoints Dr. Roscoe M. Moore, Jr. to Scientific Advisory Board
- Nov 10th, 2023 2:00 pm
NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform
- Jul 27th, 2023 12:30 pm
NovAccess Global to Participate in National Brain Tumor Society's Annual Glioblastoma Awareness Day
- Jul 13th, 2023 12:30 pm
NovAccess Global Partners with CKN Ventures to Expand its New AI-driven Precision Medicine Division
- Jun 16th, 2023 4:40 pm
NovAccess Global Launches Precision Medicine Division Using AI, Big Data and Predictive Technologies to Accelerate Personalized Healthcare Therapies
- Jun 1st, 2023 12:40 pm
NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements
- May 11th, 2023 1:00 pm
Scroll